Literature DB >> 18475636

Production of lipopolysaccharide-induced tumour necrosis factor during influenza virus infection in mice coincides with viral replication and respiratory oxidative burst.

K N Masihi1, H Hintelmann, K Madaj, G Gast.   

Abstract

Increased morbidity and mortality occur regularly during influenza epidemics. The exact mechanisms involved are not well defined but bacterial superinfection of influenza virus infected patients is considered to play an important role. In the present study, the effect of influenza virus infection on in vivo production of turnout necrosis factor (TNF) in response to bacterial stimuli was investigated. Release of TNF in mice infected by an aerosol of influenza virus was significant after administration of bacterial lipopolysaccharide (LPS) at 72 h, whereas administration of homologous influenza virus produced only modest amounts of TNF at 96 h. Significant production of TNF was observed 48 h after intravenous administration of infectious influenza in response to LPS but not with the homologous virus. TNF induced after influenza virus infection could be blocked by a specific murine anti-TNF monoclonal antibody. Higher TNF production following aerosol influenza infection correlated with peak titres of influenza virus in the lungs of infected mice and with enhanced generation of luminoldependent chemiluminscence.

Entities:  

Year:  1995        PMID: 18475636      PMCID: PMC2365635          DOI: 10.1155/S0962935195000299

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  21 in total

1.  Increased tumor necrosis factor-alpha receptor number in chronic hepatitis B virus infection.

Authors:  J Y Lau; N Sheron; K T Nouri-Aria; G J Alexander; R Williams
Journal:  Hepatology       Date:  1991-07       Impact factor: 17.425

2.  Enhancement of simian varicella virus infection in African green monkeys by recombinant human tumor necrosis factor alpha.

Authors:  K F Soike; C W Czarniecki; G Baskin; J Blanchard; D Liggitt
Journal:  J Infect Dis       Date:  1989-02       Impact factor: 5.226

3.  Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone.

Authors:  T M Folks; K A Clouse; J Justement; A Rabson; E Duh; J H Kehrl; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

4.  Tumor necrosis factor-alpha production of influenza A virus-infected macrophages and potentiating effect of lipopolysaccharides.

Authors:  M Nain; F Hinder; J H Gong; A Schmidt; A Bender; H Sprenger; D Gemsa
Journal:  J Immunol       Date:  1990-09-15       Impact factor: 5.422

5.  Stimulation of tumor necrosis factor secretion by purified influenza virus neuraminidase.

Authors:  M Houde; D J Arora
Journal:  Cell Immunol       Date:  1990-08       Impact factor: 4.868

6.  Tumor necrosis factor-alpha/cachectin enhances human immunodeficiency virus type 1 replication in primary macrophages.

Authors:  J W Mellors; B P Griffith; M A Ortiz; M L Landry; J L Ryan
Journal:  J Infect Dis       Date:  1991-01       Impact factor: 5.226

7.  Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat.

Authors:  E J Duh; W J Maury; T M Folks; A S Fauci; A B Rabson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

8.  Tumour necrosis factors alpha and beta inhibit virus replication and synergize with interferons.

Authors:  G H Wong; D V Goeddel
Journal:  Nature       Date:  1986 Oct 30-Nov 5       Impact factor: 49.962

9.  Tumour necrosis factors (alpha, beta) induced by HIV-1 in peripheral blood mononuclear cells potentiate virus replication.

Authors:  A Vyakarnam; J McKeating; A Meager; P C Beverley
Journal:  AIDS       Date:  1990-01       Impact factor: 4.177

10.  Tumor necrosis factor alpha potentiates neutrophil antimicrobial activity: increased fungicidal activity against Torulopsis glabrata and Candida albicans and associated increases in oxygen radical production and lysosomal enzyme release.

Authors:  A Ferrante
Journal:  Infect Immun       Date:  1989-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.